From Casetext: Smarter Legal Research

Calchi v. GlaxoSmithKline Consumer Healthcare Holdings (Us) LLC

United States District Court, S.D. New York
Jun 9, 2022
7:22-cv-01341-KMK (S.D.N.Y. Jun. 9, 2022)

Opinion

7:22-cv-01341-KMK 7:22-cv-02630-KMK

06-09-2022

Nancy Calchi, individually and on behalf of all others similarly situated, Plaintiff, v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, GSK Consumer Health, Inc., and Pfizer Inc. Defendants. Stacey Papalia, on behalf of herself and all others similarly situated, Plaintiff, v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC Defendant.


[PROPOSED] ORDER

HON. KENNETH M. KARAS UNITED STATES DISTRICT JUDGE

Before the Court is the Calchi and Papalia Plaintiffs' Joint Motion to Consolidate and Appoint Class Counsel. Upon consideration of the motion, the Court GRANTS the motion and ORDERS that:

(1) The above-captioned cases are consolidated for all pre-trial and trial purposes, under the Lead Case No. 7:22-cv-01341-KMK.
(2) Dovel & Luner LLP is appointed interim class counsel under Fed. R. Civ. P 23(g)(3).
(3) Plaintiffs shall file their consolidated complaint by June 15, 2022.


Summaries of

Calchi v. GlaxoSmithKline Consumer Healthcare Holdings (Us) LLC

United States District Court, S.D. New York
Jun 9, 2022
7:22-cv-01341-KMK (S.D.N.Y. Jun. 9, 2022)
Case details for

Calchi v. GlaxoSmithKline Consumer Healthcare Holdings (Us) LLC

Case Details

Full title:Nancy Calchi, individually and on behalf of all others similarly situated…

Court:United States District Court, S.D. New York

Date published: Jun 9, 2022

Citations

7:22-cv-01341-KMK (S.D.N.Y. Jun. 9, 2022)